Physician profile
Thomas C Schuler
NPI 1659340412
$7,142.84
in general payments reported to CMS, 2019-2025
11 companies · $30.28 in 2025
The $30.28 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $5,507 · 2021: $11.87 · 2022: $313 · 2024: $1,166 · 2025: $30.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $196.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $4,600.00 | 2020-2024 | Prodisc L |
| Medtronic USA, INC. | $1,837.38 | 2019-2020 | |
| Aesculap Implant Systems, LLC | $261.48 | 2020-2022 | |
| Globus Medical, INC. | $145.89 | 2022-2024 | Distal Femur Plate System |
| Augmedics INC. | $91.62 | 2020-2022 | |
| Medtronic, INC. | $58.09 | 2024 | Mazor X System |
| Nuvasive, INC. | $57.30 | 2019 | |
| Orthofix Medical, INC. | $33.75 | 2019-2022 | |
| Abbvie INC. | $30.28 | 2025 | |
| Abbott Laboratories | $15.18 | 2019 | |
| Nevro Corp. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Schuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.